• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Science 37 to launch clinical trial research operating model

Science 37 to launch clinical trial research operating model

October 23, 2015
CenterWatch Staff

Science 37, a Los Angeles-based technology-enabled clinical research company, has completed a $6.5 million Series A financing co-led by Lux Capital and dRx Capital. The investment will accelerate Science 37’s development and rollout of its new operating model, which is designed to solve some of the greatest inefficiencies in conducting clinical trials.

“Accelerating clinical trials is possible—but only if we make it easier for people to participate,” said Noah Craft, M.D., Ph.D., and co-founder and CEO of Science 37. “Clinical research design and delivery is one of the few industries that has yet to be disrupted by technology—Science 37 uses mobile engagement and locally delivered medical services to bring clinical trials to scale.”

The new funding came from Lux Ventures IV, a $350 million fund targeting early-stage science and technology ventures, and the newly formed dRx Capital, a joint venture between Qualcomm and Novartis focused on digital medicine products, services and business models.

Science 37’s new metasite operating model efficiently delivers end-to-end clinical trial services under a single contract by leveraging partnerships with national mobile nursing companies, pharmacy chains, patient advocacy groups and other technology companies to maximize efficiency. The company is built on design-thinking principles and rapid prototyping to bring innovative clinical trials to patients at home and in local care circles.

The pharmaceutical industry spends more than $50 billion annually on clinical trials. Up to 90% of those trials, however, face cost overruns and delays, and nearly 50% of research sites underperform on patient enrollment targets. Today, patients lack real-time access to information about clinical trials. More than 80% of patients say they are interested in participating in trials, but are hindered by mobility and distance from trial sites, with close to 70% of the population living more than two hours away from research sites.

The new Science 37 metasite model has the potential to accelerate biomedical discovery while reducing the cost of developing new therapies. Science 37’s technology platform, the Network Oriented Research Assistant (NORA), utilizes telemedicine and coordinates mobile workforces to overcome geographic barriers and unlocks access, so anyone can take part in trials, including underserved and minority populations. NORA puts the trial directly in patients’ hands, so research participants are better engaged with researchers and their staff. The enhanced engagement allows for better collection of high-quality real-world data, improved medication adherence and safety monitoring, and an increased likelihood of trial success.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing